Business Description
MediciNova Inc
NAICS : 325412
SIC : 2834
ISIN : US58468P2065
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 209.31 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.3 | |||||
3-Year EPS without NRI Growth Rate | 18.1 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -11.37 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.93 | |||||
9-Day RSI | 35.07 | |||||
14-Day RSI | 43.77 | |||||
6-1 Month Momentum % | 42.6 | |||||
12-1 Month Momentum % | 67.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.66 | |||||
Quick Ratio | 16.66 | |||||
Cash Ratio | 16.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.9 | |||||
Shareholder Yield % | 0.33 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -962.32 | |||||
ROE % | -17.19 | |||||
ROA % | -16.3 | |||||
ROIC % | -77.76 | |||||
ROC (Joel Greenblatt) % | -2167.33 | |||||
ROCE % | -19.83 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 99.11 | |||||
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 2.39 | |||||
EV-to-EBIT | -5.06 | |||||
EV-to-EBITDA | -5.07 | |||||
EV-to-Revenue | 60.68 | |||||
EV-to-FCF | -6.88 | |||||
Price-to-Net-Current-Asset-Value | 2.42 | |||||
Price-to-Net-Cash | 2.48 | |||||
Earnings Yield (Greenblatt) % | -19.73 | |||||
FCF Yield % | -9.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MediciNova Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 143.982 | ||
EPS (TTM) (円) | -31.218 | ||
Beta | 0.16 | ||
Volatility % | 52.7 | ||
14-Day RSI | 43.77 | ||
14-Day ATR (円) | 17.905549 | ||
20-Day SMA (円) | 325.25 | ||
12-1 Month Momentum % | 67.37 | ||
52-Week Range (円) | 155 - 354 | ||
Shares Outstanding (Mil) | 49.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MediciNova Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MediciNova Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
MediciNova Inc Frequently Asked Questions
What is MediciNova Inc(TSE:4875)'s stock price today?
When is next earnings date of MediciNova Inc(TSE:4875)?
Does MediciNova Inc(TSE:4875) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |